吉非贝齐和氯贝丁酯治疗高脂血症的比较试验。 - Suppr

Suppr

超能文献

Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.

作者信息

Eisalo A, Manninen V

出版信息

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.

DOI:10.1177/00359157760690S211

PMID:798196

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1864031/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7583/1864031/a5c1fd348e02/procrsmed00035-0051-a.jpg

相似文献

Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.

A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.

A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209.

Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217.

Gemfibrozil treatment: a comparison with clofibrate.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):88-9. doi: 10.1177/00359157760690S222.

Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):32-7. doi: 10.1177/00359157760690S208.

The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219.

The evaluation of lipoprotein changes during gemfibrozil treatment.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):76-7. doi: 10.1177/00359157760690S218.

Summary of present data from a clinical trial of CI-719.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):90-3. doi: 10.1177/00359157760690S223.

CI-719 in hyperlipoproteinaemia: interim data.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):83-7. doi: 10.1177/00359157760690S221.

引用本文的文献

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004.

本文引用的文献

Long-term effects of clofibrate (Atromid-S) on serum lipids in man.

Circulation. 1969 May;39(5):675-83. doi: 10.1161/01.cir.39.5.675.

Physical hazards.

Postgrad Med J. 1975;51 Suppl 2:suppl 51: 5-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.

A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.

A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209.

Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217.

Gemfibrozil treatment: a comparison with clofibrate.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):88-9. doi: 10.1177/00359157760690S222.

Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):32-7. doi: 10.1177/00359157760690S208.

The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219.

The evaluation of lipoprotein changes during gemfibrozil treatment.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):76-7. doi: 10.1177/00359157760690S218.

Summary of present data from a clinical trial of CI-719.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):90-3. doi: 10.1177/00359157760690S223.

CI-719 in hyperlipoproteinaemia: interim data.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):83-7. doi: 10.1177/00359157760690S221.

引用本文的文献

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004.

本文引用的文献

Long-term effects of clofibrate (Atromid-S) on serum lipids in man.

Circulation. 1969 May;39(5):675-83. doi: 10.1161/01.cir.39.5.675.

Physical hazards.

Postgrad Med J. 1975;51 Suppl 2:suppl 51: 5-9.